Source:http://linkedlifedata.com/resource/pubmed/id/10781467
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2000-5-18
|
pubmed:abstractText |
We determined the minimum effective anesthetic concentration (MEAC) of bupivacaine for spinal anesthesia, defined as the median effective concentration at which a spinal anesthetic produces surgically equivalent anesthesia within 20 min of administration in 50% of human subjects. Two doses of spinal bupivacaine (7.5 mg and 10 mg) were administered to 45 volunteers (19-39 yr) in a randomized, double-blinded fashion. Hyperbaric bupivacaine solutions of 0.1% to 0.75% containing 8.25% dextrose were administered intrathecally and MEAC established by using the Dixon's up-and-down method. Complete anesthesia was defined as: 1) pinprick anesthesia at or higher than T12; 2) anesthesia to transcutaneous tetanic electric stimulation (50 Hz at 60 mA for 5 s) in the knees; and 3) complete leg paralysis, all occurring in both lower extremities within 20 min of intrathecal injection. We found that the MEAC of spinal bupivacaine was 0.43% (95% confidence interval 0.24-0.62) when 10 mg was administered. At this dose, a concentration as low as 0.1% could provide complete anesthesia, but consistent blockade was obtained only with the 0.7% solution. The 7.5-mg dose failed to provide complete anesthesia consistently, even in the presence of 0.75% (maximum). The current commercially available 0.75% concentration of hyperbaric bupivacaine seems to be clinically optimal when 10 mg is used if complete bilateral lower extremity blockade is desired.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0003-2999
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
90
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1135-40
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10781467-Adult,
pubmed-meshheading:10781467-Anesthesia, Spinal,
pubmed-meshheading:10781467-Anesthetics, Local,
pubmed-meshheading:10781467-Bupivacaine,
pubmed-meshheading:10781467-Double-Blind Method,
pubmed-meshheading:10781467-Female,
pubmed-meshheading:10781467-Humans,
pubmed-meshheading:10781467-Male,
pubmed-meshheading:10781467-Prospective Studies,
pubmed-meshheading:10781467-Sensation
|
pubmed:year |
2000
|
pubmed:articleTitle |
Determining minimum effective anesthetic concentration of hyperbaric bupivacaine for spinal anesthesia.
|
pubmed:affiliation |
Department of Anesthesia, University of Toronto, The Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|